nodes	percent_of_prediction	percent_of_DWPC	metapath
Ertapenem—Pruritus—Teniposide—lymphatic system cancer	0.00125	0.00125	CcSEcCtD
Ertapenem—Arrhythmia—Carmustine—lymphatic system cancer	0.00125	0.00125	CcSEcCtD
Ertapenem—Depressed level of consciousness—Methotrexate—lymphatic system cancer	0.00124	0.00124	CcSEcCtD
Ertapenem—Cardiac disorder—Vincristine—lymphatic system cancer	0.00124	0.00124	CcSEcCtD
Ertapenem—Skin exfoliation—Methotrexate—lymphatic system cancer	0.00123	0.00123	CcSEcCtD
Ertapenem—Body temperature increased—Fludarabine—lymphatic system cancer	0.00122	0.00122	CcSEcCtD
Ertapenem—Mental disorder—Carmustine—lymphatic system cancer	0.00122	0.00122	CcSEcCtD
Ertapenem—Vaginal infection—Methotrexate—lymphatic system cancer	0.00121	0.00121	CcSEcCtD
Ertapenem—Erythema—Carmustine—lymphatic system cancer	0.00121	0.00121	CcSEcCtD
Ertapenem—Malnutrition—Carmustine—lymphatic system cancer	0.00121	0.00121	CcSEcCtD
Ertapenem—Cough—Bleomycin—lymphatic system cancer	0.00121	0.00121	CcSEcCtD
Ertapenem—Angiopathy—Vincristine—lymphatic system cancer	0.00121	0.00121	CcSEcCtD
Ertapenem—Diarrhoea—Teniposide—lymphatic system cancer	0.0012	0.0012	CcSEcCtD
Ertapenem—Mediastinal disorder—Vincristine—lymphatic system cancer	0.0012	0.0012	CcSEcCtD
Ertapenem—Chest pain—Bleomycin—lymphatic system cancer	0.00118	0.00118	CcSEcCtD
Ertapenem—Discomfort—Bleomycin—lymphatic system cancer	0.00117	0.00117	CcSEcCtD
Ertapenem—Mental disorder—Vincristine—lymphatic system cancer	0.00117	0.00117	CcSEcCtD
Ertapenem—Chills—Mitoxantrone—lymphatic system cancer	0.00116	0.00116	CcSEcCtD
Ertapenem—Mouth ulceration—Methotrexate—lymphatic system cancer	0.00116	0.00116	CcSEcCtD
Ertapenem—Arrhythmia—Mitoxantrone—lymphatic system cancer	0.00116	0.00116	CcSEcCtD
Ertapenem—Confusional state—Bleomycin—lymphatic system cancer	0.00114	0.00114	CcSEcCtD
Ertapenem—Hypersensitivity—Fludarabine—lymphatic system cancer	0.00114	0.00114	CcSEcCtD
Ertapenem—Tremor—Carmustine—lymphatic system cancer	0.00114	0.00114	CcSEcCtD
Ertapenem—Anaphylactic shock—Bleomycin—lymphatic system cancer	0.00113	0.00113	CcSEcCtD
Ertapenem—Oedema—Bleomycin—lymphatic system cancer	0.00113	0.00113	CcSEcCtD
Ertapenem—Erythema—Mitoxantrone—lymphatic system cancer	0.00113	0.00113	CcSEcCtD
Ertapenem—Infection—Bleomycin—lymphatic system cancer	0.00113	0.00113	CcSEcCtD
Ertapenem—Anaemia—Carmustine—lymphatic system cancer	0.00112	0.00112	CcSEcCtD
Ertapenem—Vomiting—Teniposide—lymphatic system cancer	0.00112	0.00112	CcSEcCtD
Ertapenem—Sepsis—Methotrexate—lymphatic system cancer	0.00112	0.00112	CcSEcCtD
Ertapenem—Agitation—Carmustine—lymphatic system cancer	0.00112	0.00112	CcSEcCtD
Ertapenem—Thrombocytopenia—Bleomycin—lymphatic system cancer	0.00111	0.00111	CcSEcCtD
Ertapenem—Asthenia—Fludarabine—lymphatic system cancer	0.00111	0.00111	CcSEcCtD
Ertapenem—Rash—Teniposide—lymphatic system cancer	0.00111	0.00111	CcSEcCtD
Ertapenem—Dermatitis—Teniposide—lymphatic system cancer	0.00111	0.00111	CcSEcCtD
Ertapenem—Dysgeusia—Mitoxantrone—lymphatic system cancer	0.0011	0.0011	CcSEcCtD
Ertapenem—Headache—Teniposide—lymphatic system cancer	0.0011	0.0011	CcSEcCtD
Ertapenem—Pruritus—Fludarabine—lymphatic system cancer	0.0011	0.0011	CcSEcCtD
Ertapenem—Anorexia—Bleomycin—lymphatic system cancer	0.00108	0.00108	CcSEcCtD
Ertapenem—Thrombophlebitis—Methotrexate—lymphatic system cancer	0.00108	0.00108	CcSEcCtD
Ertapenem—Diabetes mellitus—Methotrexate—lymphatic system cancer	0.00107	0.00107	CcSEcCtD
Ertapenem—Anaemia—Vincristine—lymphatic system cancer	0.00107	0.00107	CcSEcCtD
Ertapenem—Agitation—Vincristine—lymphatic system cancer	0.00106	0.00106	CcSEcCtD
Ertapenem—Hypotension—Bleomycin—lymphatic system cancer	0.00106	0.00106	CcSEcCtD
Ertapenem—Diarrhoea—Fludarabine—lymphatic system cancer	0.00106	0.00106	CcSEcCtD
Ertapenem—Convulsion—Carmustine—lymphatic system cancer	0.00105	0.00105	CcSEcCtD
Ertapenem—Hypertension—Carmustine—lymphatic system cancer	0.00105	0.00105	CcSEcCtD
Ertapenem—Ill-defined disorder—Mitoxantrone—lymphatic system cancer	0.00105	0.00105	CcSEcCtD
Ertapenem—Nausea—Teniposide—lymphatic system cancer	0.00105	0.00105	CcSEcCtD
Ertapenem—Anaemia—Mitoxantrone—lymphatic system cancer	0.00104	0.00104	CcSEcCtD
Ertapenem—Vertigo—Vincristine—lymphatic system cancer	0.00104	0.00104	CcSEcCtD
Ertapenem—Musculoskeletal discomfort—Bleomycin—lymphatic system cancer	0.00103	0.00103	CcSEcCtD
Ertapenem—Chest pain—Carmustine—lymphatic system cancer	0.00103	0.00103	CcSEcCtD
Ertapenem—Anxiety—Carmustine—lymphatic system cancer	0.00103	0.00103	CcSEcCtD
Ertapenem—Paraesthesia—Bleomycin—lymphatic system cancer	0.00102	0.00102	CcSEcCtD
Ertapenem—Malaise—Mitoxantrone—lymphatic system cancer	0.00102	0.00102	CcSEcCtD
Ertapenem—Dyspnoea—Bleomycin—lymphatic system cancer	0.00101	0.00101	CcSEcCtD
Ertapenem—Renal failure acute—Methotrexate—lymphatic system cancer	0.00101	0.00101	CcSEcCtD
Ertapenem—Convulsion—Vincristine—lymphatic system cancer	0.001	0.001	CcSEcCtD
Ertapenem—Hypertension—Vincristine—lymphatic system cancer	0.001	0.001	CcSEcCtD
Ertapenem—Confusional state—Carmustine—lymphatic system cancer	0.000999	0.000999	CcSEcCtD
Ertapenem—Oedema—Carmustine—lymphatic system cancer	0.000991	0.000991	CcSEcCtD
Ertapenem—Decreased appetite—Bleomycin—lymphatic system cancer	0.000986	0.000986	CcSEcCtD
Ertapenem—Cough—Mitoxantrone—lymphatic system cancer	0.000985	0.000985	CcSEcCtD
Ertapenem—Infection—Carmustine—lymphatic system cancer	0.000984	0.000984	CcSEcCtD
Ertapenem—Vomiting—Fludarabine—lymphatic system cancer	0.000984	0.000984	CcSEcCtD
Ertapenem—Convulsion—Mitoxantrone—lymphatic system cancer	0.000978	0.000978	CcSEcCtD
Ertapenem—Rash—Fludarabine—lymphatic system cancer	0.000976	0.000976	CcSEcCtD
Ertapenem—Dermatitis—Fludarabine—lymphatic system cancer	0.000975	0.000975	CcSEcCtD
Ertapenem—Hypertension—Mitoxantrone—lymphatic system cancer	0.000974	0.000974	CcSEcCtD
Ertapenem—Pain—Bleomycin—lymphatic system cancer	0.00097	0.00097	CcSEcCtD
Ertapenem—Thrombocytopenia—Carmustine—lymphatic system cancer	0.00097	0.00097	CcSEcCtD
Ertapenem—Headache—Fludarabine—lymphatic system cancer	0.00097	0.00097	CcSEcCtD
Ertapenem—Tachycardia—Carmustine—lymphatic system cancer	0.000967	0.000967	CcSEcCtD
Ertapenem—Anaphylactoid reaction—Methotrexate—lymphatic system cancer	0.000965	0.000965	CcSEcCtD
Ertapenem—Arthralgia—Mitoxantrone—lymphatic system cancer	0.000961	0.000961	CcSEcCtD
Ertapenem—Chest pain—Mitoxantrone—lymphatic system cancer	0.000961	0.000961	CcSEcCtD
Ertapenem—Anxiety—Mitoxantrone—lymphatic system cancer	0.000957	0.000957	CcSEcCtD
Ertapenem—Cerebrovascular accident—Methotrexate—lymphatic system cancer	0.000953	0.000953	CcSEcCtD
Ertapenem—Discomfort—Mitoxantrone—lymphatic system cancer	0.000949	0.000949	CcSEcCtD
Ertapenem—Anaphylactic shock—Vincristine—lymphatic system cancer	0.000946	0.000946	CcSEcCtD
Ertapenem—Oedema—Vincristine—lymphatic system cancer	0.000946	0.000946	CcSEcCtD
Ertapenem—Anorexia—Carmustine—lymphatic system cancer	0.000944	0.000944	CcSEcCtD
Ertapenem—Infection—Vincristine—lymphatic system cancer	0.000939	0.000939	CcSEcCtD
Ertapenem—Feeling abnormal—Bleomycin—lymphatic system cancer	0.000935	0.000935	CcSEcCtD
Ertapenem—Confusional state—Mitoxantrone—lymphatic system cancer	0.000929	0.000929	CcSEcCtD
Ertapenem—Nervous system disorder—Vincristine—lymphatic system cancer	0.000927	0.000927	CcSEcCtD
Ertapenem—Thrombocytopenia—Vincristine—lymphatic system cancer	0.000926	0.000926	CcSEcCtD
Ertapenem—Hypotension—Carmustine—lymphatic system cancer	0.000926	0.000926	CcSEcCtD
Ertapenem—Oedema—Mitoxantrone—lymphatic system cancer	0.000921	0.000921	CcSEcCtD
Ertapenem—Anaphylactic shock—Mitoxantrone—lymphatic system cancer	0.000921	0.000921	CcSEcCtD
Ertapenem—Nausea—Fludarabine—lymphatic system cancer	0.000919	0.000919	CcSEcCtD
Ertapenem—Infection—Mitoxantrone—lymphatic system cancer	0.000915	0.000915	CcSEcCtD
Ertapenem—Hyperhidrosis—Vincristine—lymphatic system cancer	0.000914	0.000914	CcSEcCtD
Ertapenem—Shock—Mitoxantrone—lymphatic system cancer	0.000906	0.000906	CcSEcCtD
Ertapenem—Musculoskeletal discomfort—Carmustine—lymphatic system cancer	0.000902	0.000902	CcSEcCtD
Ertapenem—Thrombocytopenia—Mitoxantrone—lymphatic system cancer	0.000902	0.000902	CcSEcCtD
Ertapenem—Urticaria—Bleomycin—lymphatic system cancer	0.000902	0.000902	CcSEcCtD
Ertapenem—Anorexia—Vincristine—lymphatic system cancer	0.000901	0.000901	CcSEcCtD
Ertapenem—Tachycardia—Mitoxantrone—lymphatic system cancer	0.000899	0.000899	CcSEcCtD
Ertapenem—Body temperature increased—Bleomycin—lymphatic system cancer	0.000897	0.000897	CcSEcCtD
Ertapenem—Insomnia—Carmustine—lymphatic system cancer	0.000896	0.000896	CcSEcCtD
Ertapenem—Skin disorder—Mitoxantrone—lymphatic system cancer	0.000894	0.000894	CcSEcCtD
Ertapenem—Hyperhidrosis—Mitoxantrone—lymphatic system cancer	0.00089	0.00089	CcSEcCtD
Ertapenem—Paraesthesia—Carmustine—lymphatic system cancer	0.000889	0.000889	CcSEcCtD
Ertapenem—Hypotension—Vincristine—lymphatic system cancer	0.000884	0.000884	CcSEcCtD
Ertapenem—Dyspnoea—Carmustine—lymphatic system cancer	0.000883	0.000883	CcSEcCtD
Ertapenem—Somnolence—Carmustine—lymphatic system cancer	0.000881	0.000881	CcSEcCtD
Ertapenem—Anorexia—Mitoxantrone—lymphatic system cancer	0.000878	0.000878	CcSEcCtD
Ertapenem—Musculoskeletal discomfort—Vincristine—lymphatic system cancer	0.000862	0.000862	CcSEcCtD
Ertapenem—Decreased appetite—Carmustine—lymphatic system cancer	0.000861	0.000861	CcSEcCtD
Ertapenem—Hypotension—Mitoxantrone—lymphatic system cancer	0.000861	0.000861	CcSEcCtD
Ertapenem—Insomnia—Vincristine—lymphatic system cancer	0.000855	0.000855	CcSEcCtD
Ertapenem—Gastrointestinal disorder—Carmustine—lymphatic system cancer	0.000855	0.000855	CcSEcCtD
Ertapenem—Paraesthesia—Vincristine—lymphatic system cancer	0.000849	0.000849	CcSEcCtD
Ertapenem—Constipation—Carmustine—lymphatic system cancer	0.000847	0.000847	CcSEcCtD
Ertapenem—Pain—Carmustine—lymphatic system cancer	0.000847	0.000847	CcSEcCtD
Ertapenem—Breast disorder—Methotrexate—lymphatic system cancer	0.000844	0.000844	CcSEcCtD
Ertapenem—Musculoskeletal discomfort—Mitoxantrone—lymphatic system cancer	0.000839	0.000839	CcSEcCtD
Ertapenem—Hypersensitivity—Bleomycin—lymphatic system cancer	0.000836	0.000836	CcSEcCtD
Ertapenem—Paraesthesia—Mitoxantrone—lymphatic system cancer	0.000827	0.000827	CcSEcCtD
Ertapenem—Decreased appetite—Vincristine—lymphatic system cancer	0.000822	0.000822	CcSEcCtD
Ertapenem—Dyspnoea—Mitoxantrone—lymphatic system cancer	0.000821	0.000821	CcSEcCtD
Ertapenem—Somnolence—Mitoxantrone—lymphatic system cancer	0.000819	0.000819	CcSEcCtD
Ertapenem—Gastrointestinal disorder—Vincristine—lymphatic system cancer	0.000816	0.000816	CcSEcCtD
Ertapenem—Feeling abnormal—Carmustine—lymphatic system cancer	0.000816	0.000816	CcSEcCtD
Ertapenem—Fatigue—Vincristine—lymphatic system cancer	0.000815	0.000815	CcSEcCtD
Ertapenem—Asthenia—Bleomycin—lymphatic system cancer	0.000814	0.000814	CcSEcCtD
Ertapenem—Dyspepsia—Mitoxantrone—lymphatic system cancer	0.000811	0.000811	CcSEcCtD
Ertapenem—Gastrointestinal pain—Carmustine—lymphatic system cancer	0.00081	0.00081	CcSEcCtD
Ertapenem—Pain—Vincristine—lymphatic system cancer	0.000809	0.000809	CcSEcCtD
Ertapenem—Constipation—Vincristine—lymphatic system cancer	0.000809	0.000809	CcSEcCtD
Ertapenem—Asthma—Methotrexate—lymphatic system cancer	0.000807	0.000807	CcSEcCtD
Ertapenem—Pruritus—Bleomycin—lymphatic system cancer	0.000803	0.000803	CcSEcCtD
Ertapenem—Decreased appetite—Mitoxantrone—lymphatic system cancer	0.000801	0.000801	CcSEcCtD
Ertapenem—Eosinophilia—Methotrexate—lymphatic system cancer	0.000799	0.000799	CcSEcCtD
Ertapenem—Fatigue—Mitoxantrone—lymphatic system cancer	0.000794	0.000794	CcSEcCtD
Ertapenem—Pancreatitis—Methotrexate—lymphatic system cancer	0.000791	0.000791	CcSEcCtD
Ertapenem—Pain—Mitoxantrone—lymphatic system cancer	0.000787	0.000787	CcSEcCtD
Ertapenem—Constipation—Mitoxantrone—lymphatic system cancer	0.000787	0.000787	CcSEcCtD
Ertapenem—Abdominal pain—Carmustine—lymphatic system cancer	0.000783	0.000783	CcSEcCtD
Ertapenem—Body temperature increased—Carmustine—lymphatic system cancer	0.000783	0.000783	CcSEcCtD
Ertapenem—Gastrointestinal pain—Vincristine—lymphatic system cancer	0.000773	0.000773	CcSEcCtD
Ertapenem—Feeling abnormal—Mitoxantrone—lymphatic system cancer	0.000759	0.000759	CcSEcCtD
Ertapenem—Dysuria—Methotrexate—lymphatic system cancer	0.000754	0.000754	CcSEcCtD
Ertapenem—Neutropenia—Methotrexate—lymphatic system cancer	0.000754	0.000754	CcSEcCtD
Ertapenem—Gastrointestinal pain—Mitoxantrone—lymphatic system cancer	0.000753	0.000753	CcSEcCtD
Ertapenem—Upper respiratory tract infection—Methotrexate—lymphatic system cancer	0.00075	0.00075	CcSEcCtD
Ertapenem—Abdominal pain—Vincristine—lymphatic system cancer	0.000748	0.000748	CcSEcCtD
Ertapenem—Body temperature increased—Vincristine—lymphatic system cancer	0.000748	0.000748	CcSEcCtD
Ertapenem—Urticaria—Mitoxantrone—lymphatic system cancer	0.000732	0.000732	CcSEcCtD
Ertapenem—Hypersensitivity—Carmustine—lymphatic system cancer	0.00073	0.00073	CcSEcCtD
Ertapenem—Body temperature increased—Mitoxantrone—lymphatic system cancer	0.000728	0.000728	CcSEcCtD
Ertapenem—Abdominal pain—Mitoxantrone—lymphatic system cancer	0.000728	0.000728	CcSEcCtD
Ertapenem—Pneumonia—Methotrexate—lymphatic system cancer	0.000724	0.000724	CcSEcCtD
Ertapenem—Vomiting—Bleomycin—lymphatic system cancer	0.000722	0.000722	CcSEcCtD
Ertapenem—Infestation NOS—Methotrexate—lymphatic system cancer	0.000719	0.000719	CcSEcCtD
Ertapenem—Infestation—Methotrexate—lymphatic system cancer	0.000719	0.000719	CcSEcCtD
Ertapenem—Rash—Bleomycin—lymphatic system cancer	0.000716	0.000716	CcSEcCtD
Ertapenem—Dermatitis—Bleomycin—lymphatic system cancer	0.000715	0.000715	CcSEcCtD
Ertapenem—Asthenia—Carmustine—lymphatic system cancer	0.000711	0.000711	CcSEcCtD
Ertapenem—Stomatitis—Methotrexate—lymphatic system cancer	0.000701	0.000701	CcSEcCtD
Ertapenem—Hypersensitivity—Vincristine—lymphatic system cancer	0.000697	0.000697	CcSEcCtD
Ertapenem—Sweating—Methotrexate—lymphatic system cancer	0.00069	0.00069	CcSEcCtD
Ertapenem—Haematuria—Methotrexate—lymphatic system cancer	0.000686	0.000686	CcSEcCtD
Ertapenem—Hepatobiliary disease—Methotrexate—lymphatic system cancer	0.00068	0.00068	CcSEcCtD
Ertapenem—Epistaxis—Methotrexate—lymphatic system cancer	0.000679	0.000679	CcSEcCtD
Ertapenem—Hypersensitivity—Mitoxantrone—lymphatic system cancer	0.000678	0.000678	CcSEcCtD
Ertapenem—Asthenia—Vincristine—lymphatic system cancer	0.000678	0.000678	CcSEcCtD
Ertapenem—Diarrhoea—Carmustine—lymphatic system cancer	0.000678	0.000678	CcSEcCtD
Ertapenem—Nausea—Bleomycin—lymphatic system cancer	0.000674	0.000674	CcSEcCtD
Ertapenem—Asthenia—Mitoxantrone—lymphatic system cancer	0.000661	0.000661	CcSEcCtD
Ertapenem—Dizziness—Carmustine—lymphatic system cancer	0.000655	0.000655	CcSEcCtD
Ertapenem—Haemoglobin—Methotrexate—lymphatic system cancer	0.000649	0.000649	CcSEcCtD
Ertapenem—Diarrhoea—Vincristine—lymphatic system cancer	0.000647	0.000647	CcSEcCtD
Ertapenem—Haemorrhage—Methotrexate—lymphatic system cancer	0.000646	0.000646	CcSEcCtD
Ertapenem—Pharyngitis—Methotrexate—lymphatic system cancer	0.000641	0.000641	CcSEcCtD
Ertapenem—Urinary tract disorder—Methotrexate—lymphatic system cancer	0.000638	0.000638	CcSEcCtD
Ertapenem—Urethral disorder—Methotrexate—lymphatic system cancer	0.000633	0.000633	CcSEcCtD
Ertapenem—Diarrhoea—Mitoxantrone—lymphatic system cancer	0.00063	0.00063	CcSEcCtD
Ertapenem—Vomiting—Carmustine—lymphatic system cancer	0.00063	0.00063	CcSEcCtD
Ertapenem—Dizziness—Vincristine—lymphatic system cancer	0.000625	0.000625	CcSEcCtD
Ertapenem—Rash—Carmustine—lymphatic system cancer	0.000625	0.000625	CcSEcCtD
Ertapenem—Dermatitis—Carmustine—lymphatic system cancer	0.000624	0.000624	CcSEcCtD
Ertapenem—Headache—Carmustine—lymphatic system cancer	0.000621	0.000621	CcSEcCtD
Ertapenem—Eye disorder—Methotrexate—lymphatic system cancer	0.000604	0.000604	CcSEcCtD
Ertapenem—Vomiting—Vincristine—lymphatic system cancer	0.000601	0.000601	CcSEcCtD
Ertapenem—Cardiac disorder—Methotrexate—lymphatic system cancer	0.000599	0.000599	CcSEcCtD
Ertapenem—Rash—Vincristine—lymphatic system cancer	0.000596	0.000596	CcSEcCtD
Ertapenem—Dermatitis—Vincristine—lymphatic system cancer	0.000596	0.000596	CcSEcCtD
Ertapenem—Headache—Vincristine—lymphatic system cancer	0.000592	0.000592	CcSEcCtD
Ertapenem—Nausea—Carmustine—lymphatic system cancer	0.000588	0.000588	CcSEcCtD
Ertapenem—Angiopathy—Methotrexate—lymphatic system cancer	0.000586	0.000586	CcSEcCtD
Ertapenem—Vomiting—Mitoxantrone—lymphatic system cancer	0.000586	0.000586	CcSEcCtD
Ertapenem—Immune system disorder—Methotrexate—lymphatic system cancer	0.000583	0.000583	CcSEcCtD
Ertapenem—Mediastinal disorder—Methotrexate—lymphatic system cancer	0.000582	0.000582	CcSEcCtD
Ertapenem—Rash—Mitoxantrone—lymphatic system cancer	0.000581	0.000581	CcSEcCtD
Ertapenem—Dermatitis—Mitoxantrone—lymphatic system cancer	0.00058	0.00058	CcSEcCtD
Ertapenem—Chills—Methotrexate—lymphatic system cancer	0.000579	0.000579	CcSEcCtD
Ertapenem—Headache—Mitoxantrone—lymphatic system cancer	0.000577	0.000577	CcSEcCtD
Ertapenem—Mental disorder—Methotrexate—lymphatic system cancer	0.000566	0.000566	CcSEcCtD
Ertapenem—Erythema—Methotrexate—lymphatic system cancer	0.000562	0.000562	CcSEcCtD
Ertapenem—Malnutrition—Methotrexate—lymphatic system cancer	0.000562	0.000562	CcSEcCtD
Ertapenem—Nausea—Vincristine—lymphatic system cancer	0.000562	0.000562	CcSEcCtD
Ertapenem—Dysgeusia—Methotrexate—lymphatic system cancer	0.000551	0.000551	CcSEcCtD
Ertapenem—Nausea—Mitoxantrone—lymphatic system cancer	0.000547	0.000547	CcSEcCtD
Ertapenem—Ill-defined disorder—Methotrexate—lymphatic system cancer	0.000522	0.000522	CcSEcCtD
Ertapenem—Anaemia—Methotrexate—lymphatic system cancer	0.00052	0.00052	CcSEcCtD
Ertapenem—Malaise—Methotrexate—lymphatic system cancer	0.000507	0.000507	CcSEcCtD
Ertapenem—Vertigo—Methotrexate—lymphatic system cancer	0.000505	0.000505	CcSEcCtD
Ertapenem—Cough—Methotrexate—lymphatic system cancer	0.000491	0.000491	CcSEcCtD
Ertapenem—Convulsion—Methotrexate—lymphatic system cancer	0.000487	0.000487	CcSEcCtD
Ertapenem—Arthralgia—Methotrexate—lymphatic system cancer	0.000479	0.000479	CcSEcCtD
Ertapenem—Chest pain—Methotrexate—lymphatic system cancer	0.000479	0.000479	CcSEcCtD
Ertapenem—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lymphatic system cancer	0.000475	0.000475	CcSEcCtD
Ertapenem—Discomfort—Methotrexate—lymphatic system cancer	0.000473	0.000473	CcSEcCtD
Ertapenem—Confusional state—Methotrexate—lymphatic system cancer	0.000463	0.000463	CcSEcCtD
Ertapenem—Anaphylactic shock—Methotrexate—lymphatic system cancer	0.000459	0.000459	CcSEcCtD
Ertapenem—Infection—Methotrexate—lymphatic system cancer	0.000456	0.000456	CcSEcCtD
Ertapenem—Nervous system disorder—Methotrexate—lymphatic system cancer	0.00045	0.00045	CcSEcCtD
Ertapenem—Thrombocytopenia—Methotrexate—lymphatic system cancer	0.000449	0.000449	CcSEcCtD
Ertapenem—Skin disorder—Methotrexate—lymphatic system cancer	0.000446	0.000446	CcSEcCtD
Ertapenem—Hyperhidrosis—Methotrexate—lymphatic system cancer	0.000444	0.000444	CcSEcCtD
Ertapenem—Anorexia—Methotrexate—lymphatic system cancer	0.000437	0.000437	CcSEcCtD
Ertapenem—Hypotension—Methotrexate—lymphatic system cancer	0.000429	0.000429	CcSEcCtD
Ertapenem—Musculoskeletal discomfort—Methotrexate—lymphatic system cancer	0.000418	0.000418	CcSEcCtD
Ertapenem—Insomnia—Methotrexate—lymphatic system cancer	0.000415	0.000415	CcSEcCtD
Ertapenem—Paraesthesia—Methotrexate—lymphatic system cancer	0.000412	0.000412	CcSEcCtD
Ertapenem—Dyspnoea—Methotrexate—lymphatic system cancer	0.000409	0.000409	CcSEcCtD
Ertapenem—Somnolence—Methotrexate—lymphatic system cancer	0.000408	0.000408	CcSEcCtD
Ertapenem—Dyspepsia—Methotrexate—lymphatic system cancer	0.000404	0.000404	CcSEcCtD
Ertapenem—Decreased appetite—Methotrexate—lymphatic system cancer	0.000399	0.000399	CcSEcCtD
Ertapenem—Gastrointestinal disorder—Methotrexate—lymphatic system cancer	0.000396	0.000396	CcSEcCtD
Ertapenem—Fatigue—Methotrexate—lymphatic system cancer	0.000396	0.000396	CcSEcCtD
Ertapenem—Pain—Methotrexate—lymphatic system cancer	0.000392	0.000392	CcSEcCtD
Ertapenem—Feeling abnormal—Methotrexate—lymphatic system cancer	0.000378	0.000378	CcSEcCtD
Ertapenem—Gastrointestinal pain—Methotrexate—lymphatic system cancer	0.000375	0.000375	CcSEcCtD
Ertapenem—Urticaria—Methotrexate—lymphatic system cancer	0.000364	0.000364	CcSEcCtD
Ertapenem—Abdominal pain—Methotrexate—lymphatic system cancer	0.000363	0.000363	CcSEcCtD
Ertapenem—Body temperature increased—Methotrexate—lymphatic system cancer	0.000363	0.000363	CcSEcCtD
Ertapenem—Hypersensitivity—Methotrexate—lymphatic system cancer	0.000338	0.000338	CcSEcCtD
Ertapenem—Asthenia—Methotrexate—lymphatic system cancer	0.000329	0.000329	CcSEcCtD
Ertapenem—Pruritus—Methotrexate—lymphatic system cancer	0.000325	0.000325	CcSEcCtD
Ertapenem—Diarrhoea—Methotrexate—lymphatic system cancer	0.000314	0.000314	CcSEcCtD
Ertapenem—Dizziness—Methotrexate—lymphatic system cancer	0.000303	0.000303	CcSEcCtD
Ertapenem—Vomiting—Methotrexate—lymphatic system cancer	0.000292	0.000292	CcSEcCtD
Ertapenem—Rash—Methotrexate—lymphatic system cancer	0.000289	0.000289	CcSEcCtD
Ertapenem—Dermatitis—Methotrexate—lymphatic system cancer	0.000289	0.000289	CcSEcCtD
Ertapenem—Headache—Methotrexate—lymphatic system cancer	0.000287	0.000287	CcSEcCtD
Ertapenem—Nausea—Methotrexate—lymphatic system cancer	0.000273	0.000273	CcSEcCtD
